Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation. Pharmaceutical giant Bristol Myers Squibb Co. led the Series E round with participation from several unnamed returning backers. Pathos’ investor roster includes big names such as AstraZeneca plc, NEA and General Atlantic. Pathos is developing cancer drugs […]
The post AI drug development startup Pathos AI closes $237M investment appeared first on SiliconANGLE.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry | 0 | 7.23 | 22-10-2026 |
| 2 | AI Drug Discovery Biz Valued At $3.8B After Series C Round | 0 | 5 | 14-07-2026 |
| 3 | AI cloud start-up Volta valued at $2.4bn, inks $10bn Anthropic deal | 0 | 9.38 | 05-08-2026 |
| 4 | Anthropic Quietly Launches Biolab for Drug Development - Reports | 0 | 10.85 | 18-09-2026 |
| 5 | UK AI Chip Start-Up Fractile Raises $220m | 0 | 14.49 | 14-05-2026 |
| 6 | Accel raises $3.5 billion to invest in emerging global AI startups | 0 | 10.39 | 12-08-2026 |
| 7 | Supabase raises $500M as AI coding tools drive ‘phenomenal’ growth | 0 | 11.1 | 05-06-2026 |
| 8 | Prevalent AI raises first outside capital in nine years with $22M round | 0 | 6.57 | 19-08-2026 |
| 9 | Anthropic Raising $20bn At $350bn Valuation | 0 | 12.22 | 28-01-2026 |
| 10 | Market data platform startup Databento closes $97M round after drawing $300M in investor demand | 0 | 7.53 | 09-07-2026 |